Clinical Trials · NCT05478707
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
- Phase
- Phase 2
- Recruitment status
- Suspended
- Sponsor
- University of Virginia
- Enrollment
- 47
- Start date
- Oct 2023
- Locations
- 1 site, United States
- Primary endpoint
- Microvascular blood volume (MBV)